This work presents a proof-of-concept techno-economic model of a solar-driven electrochemical plant that recovers lithium from Salar de Atacama brine while coproducing hydrogen and fixing carbon dioxide into lithium carbonate, combining two independently reported laboratory devices into a single plant-scale design. A lithium-aluminum-germanium-phosphate (LAGP) membrane cell drives lithium recovery and hydrogen evolution; a carbon-dioxide-driven precipitation stage then fixes carbon as it forms carbonate. Membrane area and photovoltaic capacity are sized jointly against a benchmark evaporation pond, and the plant is evaluated across four representative weeks of measured Atacama solar data under a literature-calibrated fixed-current baseline and a full-foresight optimal-control ceiling. The plant recovers 556–1,063 kg of lithium carbonate and 25–48 kg of hydrogen per week from a 544.9 m2 membrane, at 542–692 USD per m2 per year and 0.710 kg of CO2 fixed per kilogram of carbonate produced. Optimal control raises combined value 13.5–34.8% over the baseline across seasons, averaging 26.7%, and continuous operation replaces a 376-day brine residence time in a conventional pond. Banking the coproduced hydrogen on site for overnight fuel-cell reconversion, instead of exporting it as haul-truck fuel, adds 40–53% more lithium carbonate and repays the fuel cell's own cost in every season. Sustaining one haul truck on exported hydrogen alone would need 12,000–17,600 m2 of membrane, so on-site reconversion is the more effective use of the coproduced hydrogen at this scale.
No takes yet. Share an insight, caveat, or question.
Avendano et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: